global covid-19 oral medicine market says RationalStat

WILMINGTON, Del. - Nov. 11, 2022 - PRLog -- The report, titled "Global Covid-19 Oral Medicine Market" analyzes the market for covid-19 oral medicines worldwide based on the type of drug distribution channel, final consumer, and geography. A comprehensive report offers an in-depth analysis of the market size for the past and the future along with an analysis of trends. RationalStat offers an analysis of the market share and production capabilities of the most prominent companies, Covid-19's impact analysis, and a summary of competition, market strategies, and growth opportunities for the companies analysed in the covid-19 market study.

RationalStat has segmented the global covid-19 oral medicine market on the basis of drug class, distribution channel, end user, and region.

• By Drug Class

o   Antiviral

o   Anticoagulant

o   Monoclonal Antibodies

o   Immune Modulators

o   Others (Sedatives etc.)

• By Distribution Channel

o   Offline

o   Online

• By End User

o   Hospitals

o   Clinics

o   Home Settings

o   Others (Academic & Research Institutes)

• By Region

o   North America

§  US

§  Canada

o   Latin America

§  Brazil

§  Mexico

§  Rest of Latin America

o   Western Europe

§  Germany

§  UK

§  France

§  Spain

§  Italy

§  Rest of Western Europe

o   Eastern Europe

§  Russia

§  Poland

§  Rest of Eastern Europe

o   Asia Pacific

§  China

§  Japan

§  India

§  South Korea

§  Australia

§  ASEAN (Indonesia, Vietnam, Malaysia, etc.)

§  Rest of Asia Pacific

o   Middle East & Africa

§  GCC

§  South Africa

§  Turkey

§  Rest of the Middle East & Africa

For more information about this report https://store.rationalstat.com/store/covid-19-oral-medici...